1. Coplen DE. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis: Nguyen HT, Herndon CDA, Cooper C, et al (Children's Hosp, Boston, MA; Children's Hosp of Alabama, Birmingham; Univ of Iowa Med Ctr, Iowa City; et al) J Pediatr Urol 6:212-231, 2010. Yearb Urol. 2010; 2010:209.
2. Yamacake KG, Nguyen HT. Current management of antenatal hydronephrosis. Pediatr Nephrol. 2013; 28:237–243. PMID:
22836304.
Article
3. Mohammadjafari H, Alam A, Kosarian M, Mousavi SA, Kosarian S. Vesicoureteral reflux in neonates with hydronephrosis; role of imaging tools. Iran J Pediatr. 2009; 19:347–353.
4. Vazirian S, Mohammadjafari H, Mohammadjafari R. Postnatal management of prenatal hydronephrosis. J Clin Excell. 2013; 1:63–82.
5. Ucero AC, Benito-Martin A, Izquierdo MC, Sanchez-Nino MD, Sanz AB, Ramos AM, et al. Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol. 2014; 46:765–776. PMID:
24072452.
Article
6. Cao YS, Yu DX, Cai Y, Chao M. Diagnosis and treatment of ureteropelvic junction obstruction in children. J Appl Clin Pediatr. 2007; 22:825.
7. Klein J, Gonzalez J, Miravete M, Caubet C, Chaaya R, Decramer S, et al. Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol. 2011; 92:168–192. PMID:
20681980.
Article
8. Abedi SM, Mohammadjafari H, Hosseinimehr SJ, Mardanshahi A, Shahhosseini R. Imaging of renal cortex in nuclear medicine. J Clin Excell. 2014; 2:50–69.
9. Mohammadjafari H, Rafiei A, Abedi M, Aalaee A, Mirabi AM, Abedi E. Urinary neutrophil-gelatinase associated lipocalin is a more prognostic biomarker to distinguish antenatal hydronephrosis in neonates. Res Mol Med. 2013; 1:10–16.
Article
10. Trnka P, Hiatt MJ, Tarantal AF, Matsell DG. Congenital urinary tract obstruction: defining markers of developmental kidney injury. Pediatr Res. 2012; 72:446–454. PMID:
22902433.
Article
11. Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol. 2006; 2:157–168. PMID:
16932414.
Article
12. Mohammadjafari H, Rafiei A, Abedi M, Aalaee A, Abedi E. The role of urinary TIMP1 and MMP9 levels in predicting vesicoureteral reflux in neonates with antenatal hydronephrosis. Pediatr Nephrol. 2014; 29:871–878. PMID:
24389602.
Article
13. Sharifian M, Ahmadi M, Karimi A, Zand RE, Moghadar R, Ahmadi R, et al. Urinary endothellin-1 level in children with pyelonephritis and hydronephrosis. Saudi J Kidney Dis Transpl. 2013; 24:731–736. PMID:
23816722.
Article
14. Pollock D. Endothelin and the kidney. In : Battistini B, Warner TD, editors. Endothelin and its inhibitors. New York: Springer;2001. p. 477–501.
15. Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, et al. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int. 2000; 58:182–192. PMID:
10886563.
Article
16. Stephan M, Conrad S, Eggert T, Heuer R, Fernandez S, Huland H. Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction. J Urol. 2002; 167:1497–1502. PMID:
11832777.
Article
17. Skalova S, Rejtar P, Kutilek S. Increased urinary N-acetyl-beta-D-glucosaminidase activity in children with hydronephrosis. Int Braz J Urol. 2007; 33:80–83. PMID:
17335604.
Article
18. Ma H, Fang Y, Tian WC, Qian K, Li J, Yang JJ, et al. Clinical value of renal dynamic imaging and urinary N-acetyl-β-D-glucosaminidase, apoptosis DNA fragment detection in evaluating damage degree of hydronephrotic kidneys in children with hydronephrosis. J Appl Clin Pediatr. 2009; 16:036.
19. Csathy L, Pocsi I. Urinary N-acetyl-beta-D-glucosaminidase determination in newborns and children: methods and diagnostic applications. Eur J Clin Chem Clin Biochem. 1995; 33:575–587. PMID:
8611667.
20. Chertin B, Pollack A, Koulikov D, Rabinowitz R, Hain D, Hadas-Halpren I, et al. Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up. Eur Urol. 2006; 49:734–738. PMID:
16504374.
Article
21. Tombesi MM, Alconcher LF. Short-term outcome of mild isolated antenatal hydronephrosis conservatively managed. J Pediatr Urol. 2012; 8:129–133. PMID:
21798811.
Article
22. Chevalier RL, Thornhill BA, Forbes MS, Kiley SC. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol. 2010; 25:687–697. PMID:
19844747.
Article
23. Bartoli F, Penza R, Aceto G, Niglio F, D'ddato O, Pastore V, et al. Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction. J Pediatr Surg. 2011; 46:530–536. PMID:
21376205.
Article
24. Taranta-Janusz K, Wasilewska A, Debek W, Waszkiewicz-Stojda M. Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol. 2012; 27:2107–2113. PMID:
22744767.
Article
25. Madsen MG, Norregaard R, Palmfeldt J, Olsen LH, Frokiar J, Jorgensen TM. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. J Pediatr Urol. 2013; 9(6 Pt A):838–845. PMID:
23228281.
Article
26. Knerr I, Nyul Z, Miller J, Rosch W, Dotsch J, Repp R, et al. Increased endothelin-1 and decreased adrenomedullin gene expression in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children. BJU Int. 2001; 87:667–671. PMID:
11350409.
Article